Progress AD

Memories are precious. Even the ones you just made. The Progress AD Study is looking into a study drug to see if it could help you retain more memories and be you for longer.

What is the purpose of Progress AD?

The purpose of this study is to learn more about the study drug, GSK4527226, in adults with early Alzheimer’s disease (AD). Researchers want to find out whether the study drug can safely slow down memory loss and the decline in daily function.

Who can participate? 
You may qualify for this study if you meet the following criteria. Additional criteria to participate also apply
Age 50 to 85 years of age

Disease characteristics
Positive for amyloid accumulation in the brain as evidenced by PET scan or spinal fluid test

Mild cognitive impairment or mild dementia due to Alzheimer’s disease

Have a “study partner” to support you in study activities. Your study partner does not have to live with you but should spend at least 8 hours a week with you and be able to provide information about your daily abilities